GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AMG 139 | AMG-139 | MEDI2070
Compound class:
Antibody
Comment: Brazikumab (AMG 139, MEDI2070) is a fully human anti-IL23A monoclonal antibody in clinical development for autoimmune indications.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2011056600 [3]. |
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10425 | brazikumab |
Synonyms ![]() |
| AMG 139 | AMG-139 | MEDI2070 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 664 |
| Other databases | |
| GtoPdb PubChem SID | 318164812 |
| Search PubMed clinical trials | brazikumab |
| Search PubMed titles | brazikumab |
| Search PubMed titles/abstracts | brazikumab |